Metastatic Cancer Clinical Trials

626 clinical trials for Metastatic Cancer across international registries, including 83 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Harvesting Cells for Experimental Cancer Treatments — RECRUITING
• A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer — RECRUITING · PHASE1
• A Study of MGC026 in Participants With Advanced Solid Tumors — RECRUITING · PHASE1
• The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE) — RECRUITING · PHASE1
• A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors — RECRUITING · PHASE1
• Augsburg Longitudinal Plasma Study for the Evaluation of Liquid Biopsy as Diagnostic Tool. — RECRUITING
• Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer — RECRUITING · PHASE1
• Zanzalintinib for Metastatic Clear Cell Renal Cell Carcinoma With Bone Metastases — RECRUITING · PHASE2
• SLV-154 Treatment of Advanced Cancers — RECRUITING · PHASE1
• Y-NM600 in Patients Receiving Anti-PD-1 or Anti-PD-L1 for Metastatic Cancer — RECRUITING · PHASE1
• FOG-001 in Locally Advanced or Metastatic Solid Tumors — RECRUITING · PHASE1
• Stereotactic Ablative Radiotherapy for Oligo-Progressive Disease REfractory to Systemic Therapy in Metastatic Cancer — RECRUITING · PHASE2
• A Study of the ApricityCare Program for Early Detection and Management of Treatment-Related Adverse Events in Patients With Cancer — RECRUITING · NA
• PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival — RECRUITING · NA
• Actinium 225 Labeled Anti-CEA Antibody (Ac225-DOTA-M5A) for the Treatment of CEA Producing Advanced or Metastatic Cancers — RECRUITING · PHASE1
• Ablative Radiotherapy to Restrain Every Metastasis Safely Treatable (ARREST-2): A Randomized Phase II/III Trial — RECRUITING · NA
• Combination of Immune Checkpoint in Locally Advanced or Metastatic MSI/dMMR Esogastric Adenocarcinomas — RECRUITING · PHASE3
• KPMNG Study of MOlecular Profiling Guided Therapy Based on Genomic Alterations in Advanced Solid Tumors II — RECRUITING
• (Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal Tumors — RECRUITING · PHASE3
• Evaluating Disparities in Precision Oncology — RECRUITING
• Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer. — RECRUITING · PHASE2
• E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers — RECRUITING · PHASE2
• MEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid Tumors — RECRUITING · PHASE1
• Immune Resistance Interrogation Study — RECRUITING
• Imaging of Solid Tumors Using FAP-2286 — RECRUITING · PHASE1
• Givastomig Combined With Nivolumab and Chemotherapy in Adults With CLDN18.2 Positive Metastatic Gastric Cancer (GIVA-2) — RECRUITING · PHASE2
• Longitudinal Screening for Financial Hardship to Improve Outcomes in Patients With Advanced Cancer — RECRUITING · NA
• A Study of Reduced-dose Radiation in People With Metastatic Tumors With a Genetic Change — RECRUITING · PHASE2
• Prospective Validation of a Points Score System Predicting 30-day Survival — RECRUITING
• Pilot Study of [68Ga]Ga-ABY-025 Imaging in Patients Undergoing Treatment With HER2-targeted Therapy — RECRUITING · PHASE1
• UNC Metastatic Cancer Radiation Therapy Registry — RECRUITING
• Lattice Radiotherapy for Dose-Escalated Palliation of Bulky Tumors — RECRUITING · PHASE2
• Molecularly Targeted Theranostic Approach for the Detection and Treatment of Metastatic Carcinomas — RECRUITING · PHASE1
• A Study of JZP815 Oral Capsules in Adult Participants With Advanced or Metastatic Solid Tumors Harboring Mitogen Activated Protein Kinase (MAPK) Pathway Alterations to Investigate the Safety, Dosing, and Antitumor Activity of JZP815 — RECRUITING · PHASE1
• A Study to Assess the Ability of Stereotactic Radiotherapy to Restore the Efficacy of Immunotherapy in Patients With Metastatic Cancer. — RECRUITING · NA
• Biomarkers to Detect Endocrine Therapy Resistance — RECRUITING · PHASE2
• Comparison of Whole Body DWI to FDG PET — RECRUITING · NA
• Application of ⁶⁸Ga-FXX489 (NNS309) PET/CT Imaging in Diagnosis of Tumor Diseases. — RECRUITING · PHASE1
• Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer — RECRUITING · PHASE1
• Electronic Patient Reporting of Symptoms and Unmet Needs to Connect Patients With Advanced Cancer to Palliative Care Services — RECRUITING · NA
• Clinical Trial Assessing the Safety and Immunologic Correlates of Heterologous Prime-Boost With pNGVL4a-Sig/E7(Detox)/HSP70 and TA-HPV in Healthy Donors Followed by Peripheral Blood Collection — RECRUITING · PHASE1
• Patient Reported Outcomes/Metrics Program Trial — RECRUITING
• Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors — RECRUITING · PHASE1
• STM-06: POLARIS-POlymetastic Lesion Ablative Radiotherapy With Immunotherapy Study — RECRUITING · PHASE1
• Trastuzumab Deruxtecan (T-DXd) for People With Brain Cancer — RECRUITING · PHASE2
• Treatment of Cancer With Immune Checkpoint Inhibition Therapy Boosted by High Intensity Focused Ultrasound Histotripsy — RECRUITING · PHASE1
• Role of Ablative Radiotherapy in the Management of Metastatic Disease: A Patient Data Registry — RECRUITING
• Hybrid Arc Palliative Radiation Therapy (HART): A Single Arm Phase II Trial — RECRUITING · PHASE2
• Study of CEA Targeting CAR-T (PTC13) in the Treatment of CEA-Positive Advanced Malignant Solid Tumors — RECRUITING · PHASE1
• Parental Support Intervention in an Advanced Oncological Context — RECRUITING · NA

Refine this search